NCT00003969View on ClinicalTrials.gov

Geldanamycin Analogue in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 1998

Study Completion Date

January 31, 2007

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

tanespimycin

Trial Locations (1)

SW3 6JJ

Royal Marsden NHS Foundation Trust - London, London

Sponsors

Lead Sponsor

Cancer Research UK

All Listed Sponsors

lead

Cancer Research UK

OTHER

NCT00003969 - Geldanamycin Analogue in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter